Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs
Kailera Therapeutics’ IPO proceeds will support global clinical trials for its obesity drug candidates. Meanwhile, proteomics company Alamar Biosciences upsized its own IPO while clinical-stage biotechs Seaport Therapeutics and Hemab Therapeutics joined the IPO queue.
Your Doctors and Nurses Are Burned Out. Here’s What They Need
These day-to-day issues are directly responsible for rising rates of clinician burnout, exacerbating the serious shortage of doctors and nurses facing the US in the next decade.
Strengthening Social Security in a Changing World
The future of social security depends on the strength of our collaboration and our unwavering commitment to the people we serve. The challenges are significant, but so are the opportunities for innovation.
Wisp, Visby Partner to Expand Access to At-Home STI Test
Wisp partnered with Visby Medical to expand access to Visby’s at-home sexually transmitted infection test and provide follow-up treatment through Wisp’s telehealth platform.
CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System
CMS is rolling out its health tech ecosystem initiative with a new Medicare app library that functions like a healthcare “App Store,” aiming to make patient data more portable and accessible across vetted digital health apps.